Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes

Atherosclerosis. 2010 Nov;213(1):329-31. doi: 10.1016/j.atherosclerosis.2010.07.026. Epub 2010 Jul 27.

Abstract

Objective: Adipocyte fatty acid-binding protein (FABP4) plasma levels are higher in type 2 diabetes (T2D). Endothelial dysfunction is also common in T2D. We have investigated the relationship between circulating FABP4 levels and endothelial function in diabetic patients.

Methods: In 257 patients (105 diabetic and 152 non-diabetic) at increased risk of cardiovascular disease, we measured circulating FABP4, reactive hyperemia index (RHI) by peripheral artery tonometry, intima-media thickness, and biomarkers of inflammation, oxidation and endothelial function.

Results: In T2D subjects, FABP4 was negatively associated with endothelial function, as measured by RHI (r=-0.226, P=0.05). In a stepwise multivariate linear regression model, FABP4 was a predictor of RHI in T2D patients (P=0.04).

Conclusion: Circulating levels of FABP4 are inversely associated with endothelial function in T2D patients, as measured by RHI. We suggest a direct effect of plasma FABP4 on the vascular endothelium in those with T2D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Diabetes Mellitus, Type 2 / metabolism*
  • Endothelium, Vascular / metabolism*
  • Fatty Acid-Binding Proteins / metabolism*
  • Female
  • Humans
  • Hyperemia / pathology
  • Inflammation
  • Male
  • Middle Aged
  • Oxygen / chemistry
  • Regression Analysis
  • Risk

Substances

  • FABP4 protein, human
  • Fatty Acid-Binding Proteins
  • Oxygen